Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2020-06-25 23:07 Tx date 2020-06-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,604.76
-11,934 vol $1.14 each |
0 | |
Filed 2020-05-29 16:32 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,810 vol |
11,934 | |
Filed 2020-05-29 16:31 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,891 vol |
98,632 | |
Filed 2020-04-12 10:24 Tx date 2020-04-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+82,934 vol |
105,523 | |
Filed 2020-04-12 10:20 Tx date 2020-04-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$42,652
+59,239 vol $0.72 each |
114,538 | |
Filed 2019-04-23 22:19 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+12,846 vol |
22,589 | |
Filed 2019-04-23 17:55 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+12,846 vol |
||
Filed 2019-04-23 17:55 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+12,846 vol |
22,589 | |
Filed 2019-04-23 17:54 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$28,556
+19,295 vol $1.48 each |
55,299 | |
Filed 2019-04-18 11:56 Tx date 2019-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$100.28
+92 vol $1.09 each |
8,124 | |
Filed 2019-04-17 13:26 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,596 vol |
8,032 | |
Filed 2019-04-17 13:26 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-5,102 vol |
9,743 | |
Filed 2019-04-02 21:05 Tx date 2019-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,436 | ||
Filed 2019-04-02 20:56 Tx date 2019-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
14,845 | ||
Filed 2019-04-02 20:54 Tx date 2019-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
36,004 |